ERN GENTURIS shared a post on LinkedIn:

“Today is World Brain Tumour Awareness Day 2025

Celebrated annually on June 8th, it is a tribute to those diagnosed with a brain tumour and to their families. It is a call dedicated to raise awareness and the importance of research.

One critical aspect is understanding genetic tumour risk syndromes – conditions where inherited genetic variants significantly increase the risk of developing tumours, including Brain Tumours. Recognizing these risks can lead to earlier detection and better outcomes.

Several inherited syndromes caused by pathogenic variants increase the risk of developing brain tumours. The following syndromes are included in ERN GENTURIS:

Neurofibromatosis type 1

NF2-related schwannomatosis (very rare)

Lynch syndrome

Familial Adenomatous Polyposis

Li-Fraumeni syndrome / heritable TP53-related cancer (hTP53rc) syndrome

Rhabdoid tumor predisposition syndrome,

CMMRD

Gorlin syndrome

Melanoma/neural tumour syndrome

Through early detection, personalized care, and collaboration, ERN GENTURIS empowers families and advances research to improve outcomes. Check our website.”

Website.

A Tribute to Those Diagnosed with a Brain Tumour and to Their Families - ERN GENTURIS

Read more posts about Brain Tumor in OncoDaily.

A Tribute to Those Diagnosed with a Brain Tumour and to Their Families – ERN GENTURIS

“Today is World Brain Tumour Awareness Day 2025

Celebrated annually on June 8th, it is a tribute to those diagnosed with a brain tumour and to their families. It is a call dedicated to raise awareness and the importance of research.

One critical aspect is understanding genetic tumour risk syndromes – conditions where inherited genetic variants significantly increase the risk of developing tumours, including Brain Tumours. Recognizing these risks can lead to earlier detection and better outcomes.

Several inherited syndromes caused by pathogenic variants increase the risk of developing brain tumours. The following syndromes are included in ERN GENTURIS:

Neurofibromatosis type 1

NF2-related schwannomatosis (very rare)

Lynch syndrome

Familial Adenomatous Polyposis

Li-Fraumeni syndrome / heritable TP53-related cancer (hTP53rc) syndrome

Rhabdoid tumor predisposition syndrome,

CMMRD

Gorlin syndrome

Melanoma/neural tumour syndrome

Through early detection, personalized care, and collaboration, ERN GENTURIS empowers families and advances research to improve outcomes. Check our website.”